Ludwig N. Hantson
Presently, Ludwig N. Hantson holds the position of Chief Executive Officer & Director at Alexion Pharmaceuticals, Inc. Dr. Hantson is also on the board of Hologic, Inc. and Biotechnology Innovation Organization.
In the past Dr. Hantson occupied the position of President-Pharma Canada at Novartis AG and Chief Executive Officer-Pharma North America at Novartis Pharmaceuticals Corp. (a subsidiary of Novartis AG), President-BioScience Division at Baxter International, Inc. Chief Executive Officer of Synovis Life Technologies, Inc. and President at Baxter BioScience Corp. (both are subsidiaries of Baxter International, Inc.), Principal at Johnson & Johnson, President, Chief Executive Officer & Director at Baxalta, Inc. and Principal at Smith & Nephew NV.
Dr. Hantson received a doctorate and a graduate degree from Université Catholique de Louvain.
Transactions
| 12/16/2020 | 13,059 | Derivative/Non-derivative trans. at $157.96 per share. | 2,062,800 |
| 12/16/2020 | 72,533 | Derivative/Non-derivative trans. at $157.96 per share. | 11,457,313 |
| 12/16/2020 | 162,707 | Award at $0 per share. | 0 |
| 03/30/2020 | 3,202 | Derivative/Non-derivative trans. at $85.43 per share. | 273,547 |
| 03/02/2020 | 8,406 | Derivative/Non-derivative trans. at $90.54 per share. | 761,080 |
| 02/28/2020 | 44,201 | Award at $0 per share. | 0 |
| 02/07/2020 | 12,771 | Derivative/Non-derivative trans. at $102.97 per share. | 1,315,030 |
| 02/28/2019 | 37,198 | Award at $0 per share. | 0 |
| 02/28/2019 | 4,043 | Derivative/Non-derivative trans. at $132.92 per share. | 537,396 |
| 02/07/2019 | 13,015 | Derivative/Non-derivative trans. at $119.57 per share. | 1,556,204 |
| 12/31/2018 | 3,244 | Disposition at $95.85 per share. | 310,938 |
| 02/28/2018 | 35,760 | Award at $0 per share. | 0 |
| 02/08/2018 | 13,245 | Disposition at $116.31 per share. | 1,540,526 |
| 02/06/2018 | 95,253 | Award at $0 per share. | 0 |
| 01/02/2018 | 2,553 | Disposition at $121.63 per share. | 310,522 |
| 06/14/2017 | 10,000 | Acquisition at $116.72 per share. | 1,167,200 |
| 03/29/2017 | 28,725 | Award at $0 per share. | 0 |
